Search alternatives:
therapeutic response » therapeutic research (Expand Search)
therapeutic options » therapeutic applications (Expand Search)
heat resistance » host resistance (Expand Search), plant resistance (Expand Search), high resistance (Expand Search)
decrease heat » release heat (Expand Search)
Showing 1 - 20 results of 6,341 for search '(( decrease ((therapeutic response) OR (therapeutic options)) ) OR ( decrease heat resistance ))', query time: 0.44s Refine Results
  1. 1
    Therapeutic Administration Success Rates.

    Therapeutic Administration Success Rates. by Alani Mohanad Khalid Ahmed (22693496)

    Published 2025
    Save to List
    Saved in:
  2. 2
    CTL response following combination therapy with NDV.

    CTL response following combination therapy with NDV. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Reasons for residual limb pain and corresponding therapeutic options, adapted from Dwornik et al. [6].

    Reasons for residual limb pain and corresponding therapeutic options, adapted from Dwornik et al. [6]. by Martin C. Berli (9427264)

    Published 2020
    Save to List
    Saved in:
  4. 4
    Therapeutic effect of TAS5315 on the decrease in bone strength in a mouse CIA model.

    Therapeutic effect of TAS5315 on the decrease in bone strength in a mouse CIA model. by Daichi Akasaka (14670684)

    Published 2023
    Save to List
    Saved in:
  5. 5
    Determination of the splenic IFN-

    Determination of the splenic IFN- by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    LDH cytotoxicity assay results.

    LDH cytotoxicity assay results. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Lymphocyte proliferation assay following combination therapy with NDV.

    Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Tumor volume measurements.

    Tumor volume measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    IFN-γ cytokine measurements.

    IFN-γ cytokine measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    IL-10 levels in tumor lysates post-treatment.

    IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Tumor volume measurements.

    Tumor volume measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    MTT assay results.

    MTT assay results. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    IL-10 cytokine measurements.

    IL-10 cytokine measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    IL-4 cytokine measurements.

    IL-4 cytokine measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.

    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Clinical factors affecting renal response to dulaglutide.

    Clinical factors affecting renal response to dulaglutide. by Sungmin Kim (628527)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes

    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes by Rebecca E. Moore (9518839)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 18
    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes

    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes by Rebecca E. Moore (9518839)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 19
    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes

    The Utility of Human Milk Oligosaccharides against Group B <i>Streptococcus</i> Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes by Rebecca E. Moore (9518839)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 20
    CDK4/6 inhibition presents as a therapeutic option for pediatric and adult germ cell tumors and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms

    CDK4/6 inhibition presents as a therapeutic option for pediatric and adult germ cell tumors and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms by Margaretha Skowron (3449309)

    Published 2020
    “…</p><p><b>Conclusion:</b> Our study highlights PaRi as therapeutic options for cisplatin-resistant and -sensitive pediatric and adult GCTs. …”
    Save to List
    Saved in:

Search Tools: